82 FR 18812 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 82, Issue 76 (April 21, 2017)
Federal Motor Carrier Safety Administration
Federal Register Volume 82, Issue 76 (April 21, 2017)
| Page Range | 18812-18817 | |
| FR Document | 2017-08078 |
[Federal Register Volume 82, Number 76 (Friday, April 21, 2017)] [Notices] [Pages 18812-18817] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-08078] [[Page 18812]] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2017-0033] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of applications for exemptions; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 41 individuals for exemption from the prohibition against persons with insulin-treated diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before May 22, 2017. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2017-0033 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket numbers for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The Federal Docket Management System (FDMS) is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self- addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the Federal Motor Carrier Safety Regulations for a 2-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the 2-year period. The 41 individuals listed in this notice have recently requested such an exemption from the diabetes prohibition in 49 CFR 391.41(b)(3), which applies to drivers of CMVs in interstate commerce. Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. II. Qualifications of Applicants Darryl Bates Mr. Bates, 53, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bates understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bates meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class C CDL from Illinois. Jacob S. Beach Mr. Beach, 24, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Beach understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Beach meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Ralph N. Bonnema, Jr. Mr. Bonnema, 74, has had ITDM since 2010. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bonnema understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bonnema meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Ohio. Robert L. Brooks Mr. Brooks, 66, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Brooks understands diabetes management and monitoring, has stable control of his diabetes using [[Page 18813]] insulin, and is able to drive a CMV safely. Mr. Brooks meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class C CDL from Mississippi. Broderick J. Burgess Mr. Burgess, 30, has had ITDM since 1993. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Burgess understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Burgess meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Kansas. Jerry L. Carter Mr. Carter, 71, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Carter understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Carter meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable proliferative. He holds a Class A CDL from Illinois. Robert D. Clayton Mr. Clayton, 73, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Clayton understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Clayton meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Nevada. Christopher M. Cleland Mr. Cleland, 49, has had ITDM since 2001. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Cleland understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Cleland meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Alabama. Frank L. Creswell, III Mr. Creswell, 49, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Creswell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Creswell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Texas. Brian L. Dinger Mr. Dinger, 50, has had ITDM since 2009. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Dinger understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Dinger meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. Michael E. Fobian Mr. Fobian, 55, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Fobian understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Fobian meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from New Jersey. Cecil J. Garmon Mr. Garmon, 61, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Garmon understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Garmon meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Tennessee. Terrance M. Golden Mr. Golden, 57, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function [[Page 18814]] that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Golden understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Golden meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Arthur V. Hansard Mr. Hansard, 59, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hansard understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hansard meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Delbert L. Harris Mr. Harris, 51, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Harris understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Harris meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Mississippi. Jon C. Jones Mr. Jones, 57, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Jones understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Jones meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Idaho. Rodney W. Kirkland Mr. Kirkland, 49, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Kirkland understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kirkland meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Washington. David P. Laselle Mr. Laselle, 63, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Laselle understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Laselle meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Alaska. Jared L. Lischka Mr. Lischka, 38, has had ITDM since 2011. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Lischka understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Lischka meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Texas. Mark V. Longo Mr. Longo, 65, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Longo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Longo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Ohio. Keith A. Mattix Mr. Mattix, 66, has had ITDM since 2013. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Mattix understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Mattix meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Utah. [[Page 18815]] Ryan J. McClurg Mr. McClurg, 37, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. McClurg understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. McClurg meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New York. Michael A. McLaughlin Mr. McLaughlin, 61, has had ITDM since 2009. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. McLaughlin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. McLaughlin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New Jersey. Charles D. Paschall Mr. Paschall, 55, has had ITDM since 1989. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Paschall understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Paschall meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Kentucky. Alan Poller Mr. Poller, 61, has had ITDM since 2006. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Poller understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Poller meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. George E. Powell Mr. Powell, 66, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Powell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Powell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New Mexico. Kyle B. Rindels Mr. Rindels, 35, has had ITDM since 1994. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Rindels understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Rindels meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Minnesota. Larry J. Sobolik Mr. Sobolik, 22, has had ITDM since 2009. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Sobolik understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Sobolik meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Oklahoma. Kevin J. Story Mr. Story, 52, has had ITDM since 2015. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Story understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Story meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Maryland. Zachary A. Stovall Mr. Stovall, 26, has had ITDM since 2002. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist [[Page 18816]] certifies that Mr. Stovall understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Stovall meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Texas. Joseph Summers Mr. Summers, 22, has had ITDM since 2001. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Summers understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Summers meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Texas. Robert J. Tate Mr. Tate, 38, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Tate understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tate meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Virginia. Anthony Terrill Mr. Terrill, 48, has had ITDM since 2008. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Terrill understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Terrill meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Missouri. Danny A. Thomas Mr. Thomas, 58, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Thomas understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Thomas meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Randy D. Tyson Mr. Tyson, 61, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Tyson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Tyson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2017 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Roy T. Varner Mr. Varner, 73, has had ITDM since 2017. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Varner understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Varner meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Danny G. Washington Mr. Washington, 55, has had ITDM since 1997. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Washington understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Washington meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Mississippi. Clinton M. Westbrook Mr. Westbrook, 54, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Westbrook understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Westbrook meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. [[Page 18817]] Matthew R. Whitney Mr. Whitney, 35, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Whitney understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Whitney meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds an operator's license from Nebraska. Gary W. Wright Mr. Wright, 50, has had ITDM since 2014. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Wright understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Wright meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Virginia. Joseph D. Zimmer Mr. Zimmer, 44, has had ITDM since 2016. His endocrinologist examined him in 2017 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Zimmer understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Zimmer meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2017 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the date section of the notice. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441).\1\ The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). --------------------------------------------------------------------------- \1\ Section 4129(a) refers to the 2003 notice as a ``final rule.'' However, the 2003 notice did not issue a ``final rule'' but did establish the procedures and standards for issuing exemptions for drivers with ITDM. --------------------------------------------------------------------------- Section 4129 requires: (1) Elimination of the requirement for 3 years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the 3-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C. 31136(e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003 notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003 notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0033 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2017-0033 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: April 14, 2017. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2017-08078 Filed 4-20-17; 8:45 am] BILLING CODE 4910-EX-P
![18812 Federal Register / Vol. 82, No. 76 / Friday, April 21, 2017 / Notices
DEPARTMENT OF TRANSPORTATION acknowledgment that we received your of the vision standard at 49 CFR
comments, please include a self- 391.41(b)(10). His optometrist examined
Federal Motor Carrier Safety addressed, stamped envelope or him in 2017 and certified that he does
Administration postcard or print the acknowledgement not have diabetic retinopathy. He holds
[Docket No. FMCSA–2017–0033] page that appears after submitting a Class C CDL from Illinois.
comments on-line.
Privacy Act: In accordance with 5 Jacob S. Beach
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus U.S.C. 553(c), DOT solicits comments Mr. Beach, 24, has had ITDM since
from the public to better inform its 2016. His endocrinologist examined him
AGENCY: Federal Motor Carrier Safety rulemaking process. DOT posts these in 2017 and certified that he has had no
Administration (FMCSA), DOT. comments, without edit, including any severe hypoglycemic reactions resulting
ACTION: Notice of applications for personal information the commenter in loss of consciousness, requiring the
exemptions; request for comments. provides, to www.regulations.gov, as assistance of another person, or
described in the system of records resulting in impaired cognitive function
SUMMARY: FMCSA announces receipt of notice (DOT/ALL–14 FDMS), which can that occurred without warning in the
applications from 41 individuals for be reviewed at www.dot.gov/privacy. past 12 months and no recurrent (2 or
exemption from the prohibition against FOR FURTHER INFORMATION CONTACT: Ms. more) severe hypoglycemic episodes in
persons with insulin-treated diabetes Christine A. Hydock, Chief, Medical the last 5 years. His endocrinologist
mellitus (ITDM) operating commercial Programs Division, (202) 366–4001, certifies that Mr. Beach understands
motor vehicles (CMVs) in interstate fmcsamedical@dot.gov, FMCSA, diabetes management and monitoring,
commerce. If granted, the exemptions Department of Transportation, 1200 has stable control of his diabetes using
would enable these individuals with New Jersey Avenue SE., Room W64– insulin, and is able to drive a CMV
ITDM to operate CMVs in interstate 113, Washington, DC 20590–0001. safely. Mr. Beach meets the
commerce. Office hours are 8:30 a.m. to 5 p.m., e.t., requirements of the vision standard at
DATES: Comments must be received on Monday through Friday, except Federal 49 CFR 391.41(b)(10). His optometrist
or before May 22, 2017. holidays. examined him in 2017 and certified that
he does not have diabetic retinopathy.
ADDRESSES: You may submit comments SUPPLEMENTARY INFORMATION:
He holds an operator’s license from
bearing the Federal Docket Management I. Background Pennsylvania.
System (FDMS) Docket No. FMCSA–
2017–0033 using any of the following Under 49 U.S.C. 31136(e) and 31315, Ralph N. Bonnema, Jr.
methods: FMCSA may grant an exemption from
Mr. Bonnema, 74, has had ITDM since
• Federal eRulemaking Portal: Go to the Federal Motor Carrier Safety
2010. His endocrinologist examined him
http://www.regulations.gov. Follow the Regulations for a 2-year period if it finds
in 2017 and certified that he has had no
on-line instructions for submitting ‘‘such exemption would likely achieve a
severe hypoglycemic reactions resulting
comments. level of safety that is equivalent to or
in loss of consciousness, requiring the
• Mail: Docket Management Facility; greater than the level that would be
assistance of another person, or
U.S. Department of Transportation, 1200 achieved absent such exemption.’’ The
resulting in impaired cognitive function
New Jersey Avenue SE., West Building statute also allows the Agency to renew
that occurred without warning in the
Ground Floor, Room W12–140, exemptions at the end of the 2-year
past 12 months and no recurrent (2 or
Washington, DC 20590–0001. period. The 41 individuals listed in this
more) severe hypoglycemic episodes in
• Hand Delivery: West Building notice have recently requested such an
the last 5 years. His endocrinologist
Ground Floor, Room W12–140, 1200 exemption from the diabetes prohibition
certifies that Mr. Bonnema understands
New Jersey Avenue SE., Washington, in 49 CFR 391.41(b)(3), which applies to
diabetes management and monitoring,
DC, between 9 a.m. and 5 p.m., e.t., drivers of CMVs in interstate commerce.
has stable control of his diabetes using
Monday through Friday, except Federal Accordingly, the Agency will evaluate
insulin, and is able to drive a CMV
Holidays. the qualifications of each applicant to
safely. Mr. Bonnema meets the
• Fax: 1–202–493–2251. determine whether granting the
requirements of the vision standard at
Instructions: Each submission must exemption will achieve the required
49 CFR 391.41(b)(10). His
include the Agency name and the level of safety mandated by statute.
ophthalmologist examined him in 2017
docket numbers for this notice. Note II. Qualifications of Applicants and certified that he has stable
that all comments received will be nonproliferative diabetic retinopathy.
posted without change to http:// Darryl Bates
He holds a Class A CDL from Ohio.
www.regulations.gov, including any Mr. Bates, 53, has had ITDM since
personal information provided. Please 2016. His endocrinologist examined him Robert L. Brooks
see the Privacy Act heading below for in 2017 and certified that he has had no Mr. Brooks, 66, has had ITDM since
further information. severe hypoglycemic reactions resulting 2015. His endocrinologist examined him
Docket: For access to the docket to in loss of consciousness, requiring the in 2017 and certified that he has had no
read background documents or assistance of another person, or severe hypoglycemic reactions resulting
comments, go to http:// resulting in impaired cognitive function in loss of consciousness, requiring the
www.regulations.gov at any time or that occurred without warning in the assistance of another person, or
Room W12–140 on the ground level of past 12 months and no recurrent (2 or resulting in impaired cognitive function
sradovich on DSK3GMQ082PROD with NOTICES
the West Building, 1200 New Jersey more) severe hypoglycemic episodes in that occurred without warning in the
Avenue SE., Washington, DC, between 9 the last 5 years. His endocrinologist past 12 months and no recurrent (2 or
a.m. and 5 p.m., e.t., Monday through certifies that Mr. Bates understands more) severe hypoglycemic episodes in
Friday, except Federal holidays. The diabetes management and monitoring, the last 5 years. His endocrinologist
Federal Docket Management System has stable control of his diabetes using certifies that Mr. Brooks understands
(FDMS) is available 24 hours each day, insulin, and is able to drive a CMV diabetes management and monitoring,
365 days each year. If you want safely. Mr. Bates meets the requirements has stable control of his diabetes using
VerDate Sep<11>2014 17:30 Apr 20, 2017 Jkt 241001 PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 E:\FR\FM\21APN1.SGM 21APN1](https://thefederalregister.org/doc/82_FR_18888/page/1.svg)
![Federal Register / Vol. 82, No. 76 / Friday, April 21, 2017 / Notices 18817
Matthew R. Whitney he does not have diabetic retinopathy. IV. Submitting Comments
He holds a Class A CDL from Illinois.
Mr. Whitney, 35, has had ITDM since You may submit your comments and
2016. His endocrinologist examined him III. Request for Comments material online or by fax, mail, or hand
in 2017 and certified that he has had no delivery, but please use only one of
severe hypoglycemic reactions resulting In accordance with 49 U.S.C. 31136(e)
these means. FMCSA recommends that
in loss of consciousness, requiring the and 31315, FMCSA requests public
comment from all interested persons on you include your name and a mailing
assistance of another person, or address, an email address, or a phone
resulting in impaired cognitive function the exemption petitions described in
this notice. We will consider all number in the body of your document
that occurred without warning in the so that FMCSA can contact you if there
past 12 months and no recurrent (2 or comments received before the close of
business on the closing date indicated are questions regarding your
more) severe hypoglycemic episodes in submission.
the last 5 years. His endocrinologist in the date section of the notice.
certifies that Mr. Whitney understands FMCSA notes that section 4129 of the To submit your comment online, go to
diabetes management and monitoring, Safe, Accountable, Flexible and http://www.regulations.gov and in the
has stable control of his diabetes using Efficient Transportation Equity Act: A search box insert the docket number
insulin, and is able to drive a CMV Legacy for Users requires the Secretary FMCSA–2017–0033 and click the search
safely. Mr. Whitney meets the to revise its diabetes exemption program button. When the new screen appears,
requirements of the vision standard at established on September 3, 2003 (68 FR click on the blue ‘‘Comment Now!’’
49 CFR 391.41(b)(10). His optometrist 52441).1 The revision must provide for button on the right hand side of the
examined him in 2017 and certified that individual assessment of drivers with page. On the new page, enter
he does not have diabetic retinopathy. diabetes mellitus, and be consistent information required including the
He holds an operator’s license from with the criteria described in section specific section of this document to
Nebraska. 4018 of the Transportation Equity Act which each comment applies, and
for the 21st Century (49 U.S.C. 31305). provide a reason for each suggestion or
Gary W. Wright
Section 4129 requires: (1) Elimination recommendation. If you submit your
Mr. Wright, 50, has had ITDM since of the requirement for 3 years of comments by mail or hand delivery,
2014. His endocrinologist examined him experience operating CMVs while being submit them in an unbound format, no
in 2017 and certified that he has had no treated with insulin; and (2) larger than 81⁄2 by 11 inches, suitable for
severe hypoglycemic reactions resulting establishment of a specified minimum copying and electronic filing. If you
in loss of consciousness, requiring the period of insulin use to demonstrate submit comments by mail and would
assistance of another person, or stable control of diabetes before being like to know that they reached the
resulting in impaired cognitive function allowed to operate a CMV. facility, please enclose a stamped, self-
that occurred without warning in the In response to section 4129, FMCSA addressed postcard or envelope.
past 12 months and no recurrent (2 or made immediate revisions to the
more) severe hypoglycemic episodes in We will consider all comments and
diabetes exemption program established material received during the comment
the last 5 years. His endocrinologist by the September 3, 2003 notice.
certifies that Mr. Wright understands period. FMCSA may issue a final
FMCSA discontinued use of the 3-year determination at any time after the close
diabetes management and monitoring, driving experience and fulfilled the
has stable control of his diabetes using of the comment period.
requirements of section 4129 while
insulin, and is able to drive a CMV continuing to ensure that operation of V. Viewing Comments and Documents
safely. Mr. Wright meets the CMVs by drivers with ITDM will
requirements of the vision standard at achieve the requisite level of safety To view comments, as well as any
49 CFR 391.41(b)(10). His optometrist required of all exemptions granted documents mentioned in this preamble,
examined him in 2016 and certified that under 49 U.S.C. 31136(e). go to http://www.regulations.gov and in
he does not have diabetic retinopathy. the search box insert the docket number
He holds a Class A CDL from Virginia. Section 4129(d) also directed FMCSA
to ensure that drivers of CMVs with FMCSA–2017–0033 and click ‘‘Search.’’
Joseph D. Zimmer ITDM are not held to a higher standard Next, click ‘‘Open Docket Folder’’ and
than other drivers, with the exception of you will find all documents and
Mr. Zimmer, 44, has had ITDM since limited operating, monitoring and comments related to this notice.
2016. His endocrinologist examined him medical requirements that are deemed Issued on: April 14, 2017.
in 2017 and certified that he has had no medically necessary.
severe hypoglycemic reactions resulting Larry W. Minor,
in loss of consciousness, requiring the The FMCSA concluded that all of the Associate Administrator for Policy.
assistance of another person, or operating, monitoring and medical [FR Doc. 2017–08078 Filed 4–20–17; 8:45 am]
resulting in impaired cognitive function requirements set out in the September 3, BILLING CODE 4910–EX–P
that occurred without warning in the 2003 notice, except as modified, were in
past 12 months and no recurrent (2 or compliance with section 4129(d).
more) severe hypoglycemic episodes in Therefore, all of the requirements set
the last 5 years. His endocrinologist out in the September 3, 2003 notice,
certifies that Mr. Zimmer understands except as modified by the notice in the
sradovich on DSK3GMQ082PROD with NOTICES
diabetes management and monitoring, Federal Register on November 8, 2005
has stable control of his diabetes using (70 FR 67777), remain in effect.
insulin, and is able to drive a CMV
1 Section 4129(a) refers to the 2003 notice as a
safely. Mr. Zimmer meets the
‘‘final rule.’’ However, the 2003 notice did not issue
requirements of the vision standard at a ‘‘final rule’’ but did establish the procedures and
49 CFR 391.41(b)(10). His optometrist standards for issuing exemptions for drivers with
examined him in 2017 and certified that ITDM.
VerDate Sep<11>2014 17:30 Apr 20, 2017 Jkt 241001 PO 00000 Frm 00090 Fmt 4703 Sfmt 9990 E:\FR\FM\21APN1.SGM 21APN1](https://thefederalregister.org/doc/82_FR_18888/page/6.svg)
Document Created: 2017-04-21 01:19:01
Document Modified: 2017-04-21 01:19:01
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemptions; request for comments. | |
| Dates | Comments must be received on or before May 22, 2017. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. | |
| FR Citation | 82 FR 18812 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR